Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database

Roberto, Giuseppe et al.

Springer Nature OA · Papers · License: Open Access

Medicine & Public Health, Drug Safety and Pharmacovigilance, Pharmacology/Toxicology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172253
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.